http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0307827-A3

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-02
filingDate 1988-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1989-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0307827-A3
titleOfInvention Novel macromolecular complexes, process for producing same and medicinal use of such complexes
abstract A dextran or hydroxyethyl starch derivative having none or more carboxylated active sites resulting from nreaction with an aliphatic di-, tri- or tetrabasic acid nor a reactive derivative thereof, wherein one hydrogen natom of the group of the formula n n- n-OH noccurring at said active sites is partly substituted by na group of the general formula n nwherein L¹ and L² each independently is ammine or a nunidentate ligand amine or combinedly represent a nbidentate ligand amine and Y is an anionic ligand, nand/or two hydrogen atoms of n ntwo - n-OH groups bound to one and the same carbon atom nor to two neighboring carbon atoms as occurring at said nactive sites are, each independently, partly substituted nby a group of the general formula n nwherein L¹ and L² are as defined above, and a npharmacologically acceptable salt thereof. n The above compound has anticancer activity and is nuseful as anticancer agents.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8466277-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8017739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8840879-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8287850-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8475765-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916518-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8618266-B2
priorityDate 1987-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6272615-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0190464-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0111388-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974

Total number of triples: 25.